Dermatomyositis‐lupus overlap syndrome complicated with cardiomyopathy after SARS‐CoV‐2 infection: A new potential trigger for musculoskeletal autoimmune disease development | Zendy

Shahidi Dadras Mohammad | Zendy; Rakhshan Azadeh | Zendy; Ahmadzadeh Arman | Zendy; Hosseini Seyed Ali | Zendy; Diab Reem | Zendy; Safari Giv Toktam | Zendy; Abdollahimajd Fahimeh | Zendy

Open Access

Dermatomyositis‐lupus overlap syndrome complicated with cardiomyopathy after SARS‐CoV‐2 infection: A new potential trigger for musculoskeletal autoimmune disease development

Author(s) -

Shahidi Dadras Mohammad,

Rakhshan Azadeh,

Ahmadzadeh Arman,

Hosseini Seyed Ali,

Diab Reem,

Safari Giv Toktam,

Abdollahimajd Fahimeh

Publication year - 2021

Publication title -

clinical case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.21

H-Index - 9

ISSN - 2050-0904

DOI - 10.1002/ccr3.4931

Subject(s) - medicine , dermatomyositis , covid-19 , systemic lupus erythematosus , overlap syndrome , disease , cardiomyopathy , myocarditis , immunology , autoimmune disease , pandemic , viral infection , dermatology , heart failure , virus , infectious disease (medical specialty)

COVID‐19 should be considered as a new triggering factor for autoimmune disorders like DM‐lupus overlap syndrome. We recommend that patients presenting with dermatomyositis during this pandemic be screened for COVID‐19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research